
Summer 2026
By Bethany Herrema
Photography by Sam Ogden
Barbara Ludinsky generously contributed $100,000 to advance the chronic lymphocytic leukemia research of Matthew Davids, MD, MMSc, at Dana-Farber Cancer Institute. Her investment empowers studies focused on TP53-related genes and the development of next-generation combination therapies. This innovative work has tremendous potential to improve care and bring renewed hope to patients worldwide.
